Rachel Codd

3.4k total citations
87 papers, 2.8k citations indexed

About

Rachel Codd is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Rachel Codd has authored 87 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 26 papers in Organic Chemistry and 23 papers in Oncology. Recurrent topics in Rachel Codd's work include Chemical Synthesis and Analysis (13 papers), Metal complexes synthesis and properties (13 papers) and Chromium effects and bioremediation (10 papers). Rachel Codd is often cited by papers focused on Chemical Synthesis and Analysis (13 papers), Metal complexes synthesis and properties (13 papers) and Chromium effects and bioremediation (10 papers). Rachel Codd collaborates with scholars based in Australia, United States and United Kingdom. Rachel Codd's co-authors include Barry V. McCleary, Peter A. Lay, Aviva Levina, Cho Zin Soe, Joe Liu, Daniel Obando, Vivian W. Y. Liao, Carolyn T. Dillon, P. Simpson and William Tieu and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Molecular Biology and Biochemistry.

In The Last Decade

Rachel Codd

84 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel Codd Australia 28 868 557 478 466 464 87 2.8k
Julia L. Brumaghim United States 31 647 0.7× 1.3k 2.3× 655 1.4× 475 1.0× 405 0.9× 61 3.9k
Daniela Hudecová Slovakia 21 550 0.6× 539 1.0× 247 0.5× 341 0.7× 573 1.2× 74 2.6k
Maurizio Remelli Italy 34 1.2k 1.4× 521 0.9× 791 1.7× 411 0.9× 644 1.4× 103 3.4k
Joanna Izabela Lachowicz Italy 29 716 0.8× 833 1.5× 293 0.6× 419 0.9× 886 1.9× 86 3.0k
Dean E. Wilcox United States 33 1.3k 1.5× 601 1.1× 582 1.2× 546 1.2× 888 1.9× 80 3.7k
Peter‐Leon Hagedoorn Netherlands 33 1.5k 1.7× 245 0.4× 480 1.0× 570 1.2× 167 0.4× 127 3.2k
Gail R. Willsky United States 26 978 1.1× 357 0.6× 311 0.7× 1.6k 3.4× 476 1.0× 36 3.0k
David I. Pattison Australia 39 2.2k 2.5× 703 1.3× 524 1.1× 410 0.9× 138 0.3× 91 6.2k
M. Amélia Santos Portugal 35 869 1.0× 1.5k 2.8× 304 0.6× 397 0.9× 734 1.6× 165 4.2k
Gregory I. Giles New Zealand 28 1.5k 1.8× 913 1.6× 496 1.0× 232 0.5× 322 0.7× 53 3.8k

Countries citing papers authored by Rachel Codd

Since Specialization
Citations

This map shows the geographic impact of Rachel Codd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Codd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Codd more than expected).

Fields of papers citing papers by Rachel Codd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Codd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Codd. The network helps show where Rachel Codd may publish in the future.

Co-authorship network of co-authors of Rachel Codd

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Codd. A scholar is included among the top collaborators of Rachel Codd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Codd. Rachel Codd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Codd, Rachel, et al.. (2025). Directing the chemoenzymatic assembly of desferrioxamine B as a single product using N-tert-butoxycarbonyl-protected substrates. Organic & Biomolecular Chemistry. 23(30). 7181–7187.
2.
Hibbs, David E., et al.. (2025). Carboxamide-Bearing Panobinostat Analogues Designed To Interact with E103-D104 at the Cavity Opening of Class I HDAC Isoforms. ACS Medicinal Chemistry Letters. 16(2). 250–257.
3.
Codd, Rachel, et al.. (2024). A Mild and Modular Approach to the Total Synthesis of Desferrioxamine B. The Journal of Organic Chemistry. 89(7). 5118–5125. 3 indexed citations
4.
Font, Josep, et al.. (2024). An elastic siderophore synthetase and rubbery substrates assemble multimeric linear and macrocyclic hydroxamic acid metal chelators. Chemical Science. 16(5). 2180–2190. 2 indexed citations
5.
White, Melanie Y., et al.. (2023). Reduction-cleavable desferrioxamine B pulldown system enriches Ni(ii)-superoxide dismutase from a Streptomyces proteome. RSC Chemical Biology. 4(12). 1064–1072. 1 indexed citations
6.
Shon, Ivan Ho, et al.. (2022). A first-in-human study of [68Ga]Ga-CDI: a positron emitting radiopharmaceutical for imaging tumour cell death. European Journal of Nuclear Medicine and Molecular Imaging. 49(12). 4037–4047. 4 indexed citations
7.
Codd, Rachel, et al.. (2020). Immobilized Metal Affinity Chromatography as a Drug Discovery Platform for Metalloenzyme Inhibitors. Journal of Medicinal Chemistry. 63(20). 12116–12127. 5 indexed citations
8.
Codd, Rachel, et al.. (2020). Improved Access to Linear Tetrameric Hydroxamic Acids with Potential as Radiochemical Ligands for Zirconium(iv)-89 PET Imaging. Australian Journal of Chemistry. 73(10). 969–978. 11 indexed citations
9.
Tieu, William, et al.. (2019). Exploring hydroxamic acid inhibitors of HDAC1 and HDAC2 using small molecule tools and molecular or homology modelling. Bioorganic & Medicinal Chemistry Letters. 29(18). 2581–2586. 3 indexed citations
10.
Tieu, William, et al.. (2019). Analogues of desferrioxamine B (DFOB) with new properties and new functions generated using precursor-directed biosynthesis. BioMetals. 32(3). 395–408. 13 indexed citations
11.
12.
Holland, Jason P., et al.. (2019). endo-Hydroxamic Acid Monomers for the Assembly of a Suite of Non-native Dimeric Macrocyclic Siderophores Using Metal-Templated Synthesis. Inorganic Chemistry. 58(20). 13591–13603. 11 indexed citations
13.
Codd, Rachel, et al.. (2018). Engineering a cleavable disulfide bond into a natural product siderophore using precursor-directed biosynthesis. Chemical Communications. 54(70). 9813–9816. 9 indexed citations
14.
Codd, Rachel, et al.. (2018). Rubik’s Cube of Siderophore Assembly Established from Mixed-Substrate Precursor-Directed Biosynthesis. ACS Omega. 3(12). 18160–18169. 4 indexed citations
16.
Tieu, William, et al.. (2017). Octadentate Zirconium(IV)-Loaded Macrocycles with Varied Stoichiometry Assembled From Hydroxamic Acid Monomers using Metal-Templated Synthesis. Inorganic Chemistry. 56(6). 3719–3728. 31 indexed citations
17.
Tieu, William, et al.. (2017). Dimeric and trimeric homo- and heteroleptic hydroxamic acid macrocycles formed using mixed-ligand Fe(III)-based metal-templated synthesis. Journal of Inorganic Biochemistry. 177. 344–351. 9 indexed citations
18.
Tieu, William, et al.. (2017). Exploiting the biosynthetic machinery of Streptomyces pilosus to engineer a water-soluble zirconium(iv) chelator. Organic & Biomolecular Chemistry. 15(27). 5719–5730. 40 indexed citations
19.
Codd, Rachel, et al.. (2017). Advances in the Chemical Biology of Desferrioxamine B. ACS Chemical Biology. 13(1). 11–25. 75 indexed citations
20.
Tieu, William, et al.. (2016). Reverse Biosynthesis: Generating Combinatorial Pools of Drug Leads from Enzyme‐Mediated Fragmentation of Natural Products. ChemBioChem. 18(4). 368–373. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026